Today

Agents

Chat

Arena

Discover

More

App

Dyne Therapeutics launches USD 300 million common stock offering - DYN News | Rallies

Dyne Therapeutics launches USD 300 million common stock offering

DYN•2026-07-21

Dyne Therapeutics launches common stock offering

Dyne Therapeutics launched an underwritten public offering of USD 300 million of common stock.

Underwriters hold a 30-day option to buy up to an additional USD 45 million of common stock.

Morgan Stanley, Jefferies and Evercore ISI lead the deal; LifeSci Capital and Raymond James also act as bookrunners.

Offering terms remain subject to market conditions.

Related News

First Financial Bancorp Q2 EPS USD 0.73

FFBC•2026-07-21

Nurix Therapeutics Announces Hart-Scott-Rodino Clearance Of Global Collaboration With Roche To Co-Develop And Co-Commercialize Potential Best-In-Class Btk Degrader Bexobrutideg Across Malignant Hematology, Immunology And Neurology

NRIX•2026-07-21

Public Service Co Of New Mexico Enters $195 Million Term Loan Agreement On July 21, 2026 - SEC Filing

TXNM•2026-07-21

Higher copper prices push Grupo Mexico quarterly profit up 79%

XLB•2026-07-21

Norfolk Southern Declares Quarterly Dividend

NSC•2026-07-21